GSK rejigs top China management as probe widens
This article was originally published in Scrip
Executive Summary
As the Chinese corruption probe of GlaxoSmithKline rumbles on, it has emerged that the UK-based pharma giant has appointed a new general manager for China, as authorities there indicated that additional individuals have come under investigation.